Fasting glucose level modulates cell surface expression of CD11b and CD66b in granulocytes and monocytes of patients with type 2 diabetes

Journal of Investigative Medicine

Volumn 61, Issue 6, 2013, Pages 972-977

  Horvath, Peter ^a   Oliver, Stacy R ^a   Ganesan, Goutham ^a   Zaldivar Jr, Frank P ^a   Radom Aizik, Shlomit ^a   Galassetti, Pietro R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glucose; Granulocytes; Monocytes; Type 2 diabetes

Indexed keywords

CD11B ANTIGEN; CD66B ANTIGEN; GLUCOSE; METFORMIN; UNCLASSIFIED DRUG; CD14 ANTIGEN; CD16 ANTIGEN; GLYCOPROTEIN; L SELECTIN; LYMPHOCYTE ANTIGEN; MEMBRANE PROTEIN;

ADULT; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GLUCOSE BLOOD LEVEL; GRANULOCYTE; HUMAN; HYPERGLYCEMIA; INCUBATION TIME; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; ROOM TEMPERATURE; BLOOD VESSEL INJURY; BODY MASS; CELL ADHESION; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD; ANTIGENS, CD11B; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CELL ADHESION MOLECULES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; GRANULOCYTES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MONOCYTES; SURFACE PROPERTIES;

EID: 84888346959     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3182961517     Document Type: Article

References (52)

1. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98-107.
2. Hatanaka E, Monteagudo PT, Marrocos MS, et al. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol. 2006;146:443-447.
3. Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol. 1991;139:81-100.
4. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol. 2010;7:77-86.
5. Arroyo-Espliguero R, Avanzas P, Jeffery S, et al. CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart. 2004;90:983-988.
6. Gratchev A, Sobenin I, Orekhov A, et al. Monocytes as a diagnostic marker of cardiovascular diseases. Immunobiology. 2012;217:476-482.
7. Kim CH, Vaziri ND, Rodriguez-Iturbe B. Integrin expression and H2O2 production in circulating and splenic leukocytes of obese rats. Obesity (Silver Spring). 2007;15:2209-2216.
8. Barouch FC, Miyamoto K, Allport JR, et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci. 2000;41:1153-1158
9. Takeda Y, Marumo M, Wakabayashi I. Attenuated phagocytic activity of monocytes in type 2 diabetic Goto-Kakizaki rats. Immunobiology. 2011;216:1094-1102.
10. Mastej K, Adamiec R. [Neutrophil surface expression of adhesion molecule CD11b in patients with type 2 diabetes]. Przegl Lek. 2009;66:228-232.
11. Rao KM, Hatchell DL, Cohen HJ, et al. Alterations in stimulus-induced integrin expression in peripheral blood neutrophils of patients with diabetic retinopathy. Am J Med Sci. 1997;313:131-137.
12. Caimi G, Montana M, Ferrara F, et al. Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications. Acta Diabetol. 2003;40:14-19.
13. Okano K, Araki M, Yamamoto M, et al. Exploration of hematological and immunological changes associated with the severity of type 2 diabetes mellitus in Japan. Nurs Health Sci. 2008;10:65-69.
14. Mastej K, Adamiec R. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy. Acta Diabetol. 2008;45:183-190.
15. van Oostrom AJ, van Wijk JP, Sijmonsma TP, et al. Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes. Neth J Med. 2004;62:320-325.
16. Viardot A, Lord RV, Samaras K. The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes. J Clin Endocrinol Metab. 2010;95:2845-2850.
17. Walrand S, Guillet C, Boirie Y, et al. In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions. J Leukoc Biol. 2004;76:1104-1110.
18. Mazor R, Shurtz-Swirski R, Farah R, et al. Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients. Atherosclerosis. 2008;197:937-943.
19. Gawlowski T, Stratmann B, Stirban AO, et al. AGEs and methylglyoxal induce apoptosis and expression of Mac-1 on neutrophils resulting in platelet-neutrophil aggregation. Thromb Res. 2007;121:117-126.
20. Nareika A, Im YB, Game BA, et al. High glucose enhances lipopolysaccharide-stimulated CD14 expression in U937 mononuclear cells by increasing nuclear factor kappaB and AP-1 activities. J Endocrinol. 2008;196:45-55.
21. Liu DQ, Li LM, Guo YL, et al. Signal regulatory protein alpha negatively regulates beta2 integrin Ymediated monocyte adhesion, transendothelial migration and phagocytosis. PLoS One 2008;3:e3291.
22. Zhang WY, Schwartz E, Wang Y, et al. Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells. Arterioscler Thromb Vasc Biol. 2006;26:514-519.
23. Yun JM, Jialal I, Devaraj S. Epigenetic regulation of high glucose Yinduced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem. 2011;22:450-458.
24. Poitou C, Dalmas E, Renovato M, et al. 14dimCD16+ and CD14+ CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31:2322-2330.
25. Cifarelli V, Libman IM, Deluca A, et al. Increased expression of monocyte CD11b (Mac-1) in overweight recent-onset type 1 diabetic children. Rev Diabet Stud. 2007;4:112-117.
26. Mysliwska J, Smardzewski M, Marek-Trzonkowska N, et al. Expansion of CD14(+)CD16(+) monocytes producing TNF-alpha in complication-free diabetes type 1 juvenile onset patients. Cytokine. 2012;60;309-317.
27. Yang M, Gan H, Shen Q, et al. Proinflammatory CD14+CD16+ monocytes are associated with microinflammation in patients with type 2 diabetes mellitus and diabetic nephropathy uremia. Inflammation. 2012;35:388-396.
28. Fogelstrand L, Hulthe J, Hulten LM, et al. Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance. Diabetologia. 2004;47:1948-1952.
29. Farah R, Shurtz-Swirski R, Lapin O, et al. Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment. Cardiovasc Diabetol. 2008;7:20.
30. Bernal-Lopez MR, Llorente-Cortes V, Calleja F, et al. Effect of different degrees of impaired glucose metabolism on the expression of inflammatory markers in monocytes of patients with atherosclerosis. Acta Diabetol. 2011 Oct 14. [Epub ahead of print].
31. Cipolletta C, Ryan KE, Hanna EV, et al. Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes. 2005;54:2779-2786.
32. Horvath P, Ganesan G, Oliver S, et al. The in vivo effect of different concentrations of glucose on innate immune cell activation. FASEB J. 2011;25:A638.7.
33. Galassetti PR, Iwanaga K, Pontello AM, et al. Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes. Am J Physiol Endocrinol Metab. 2006;290:E833-E839
34. Rosa JS, Flores RL, Oliver SR, et al. Resting and exercise-induced IL-6 levels in children with type 1 diabetes reflect hyperglycemic profiles during the previous 3 days. J Appl Physiol. 2010;108:334-342.
35. Kassirer M, Zeltser D, Prochorov V, et al. Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: further evidence for smoldering inflammation in patients with atherosclerosis. Am Heart J. 1999;138:555-559.
36. Ionita MG, van den BP, Catanzariti LM, et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol. 2010;30:1842-1848.
37. Rogacev KS, Ulrich C, Blomer L, et al. Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur Heart J. 2010;31:369-376.
38. Berg KE, Ljungcrantz I, Andersson L, et al. Elevated CD14++CD16-monocytes predict cardiovascular events. Circ Cardiovasc Genet. 2012;5:122-131.
39. Schlitt A, Heine GH, Blankenberg S, et al. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost. 2004;92:419-424.
40. Heine GH, Ulrich C, Seibert E, et al. CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int. 2008;73:622-629.
41. Rogacev KS, Seiler S, Zawada AM, et al. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J. 2011;32:84-92.
42. Rothe G, Gabriel H, Kovacs E, et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1996;16:1437-1447.
43. Zarbock A, Ley K. Neutrophil adhesion and activation under flow. Microcirculation. 2009;16:31-42.
44. Walcheck B, Alexander SR, St Hill CA, et al. ADAM-17-independent shedding of L-selectin. J Leukoc Biol. 2003;74:389-394.
45. Tacke F, Alvarez D, Kaplan TJ, et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest. 2007;117:185-194.
46. Oya-Ito T, Naitou H, Masuda S, et al. Functional analyses of neutrophil-like differentiated cell lines under a hyperglycemic condition. Mol Nutr Food Res. 2008;52:360-369.
47. Kwon KB, Kim EK, Lim JG, et al. Sophorae radix extract inhibits high glucose-induced vascular cell adhesion molecule-1 up-regulation on endothelial cell line. Clin Chim Acta. 2004;348:79-86.
48. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-1801.
49. Glynn P, Coakley R, Kilgallen I, et al. Neutrophil CD11b and soluble ICAM-1 E-selectin in community acquired pneumonia. Eur Respir J. 1999;13:1380-1385.
50. Noble JM, Ford GA, Thomas TH. Effect of aging on CD11b and CD69 surface expression by vesicular insertion in human polymorphonuclear leucocytes. Clin Sci (Lond). 1999;92:323-329.
51. Ford ES. Body mass index, diabetes and C-reactive protein among US adults. Diabetes Care. 1999;22:1971-1977.
52. Sjoholm A, Nystrom T. Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev. 2006;22:4-10.